Revenue grew 7.3% year-over-year to EUR 640.4 million, with double-digit organic growth and margin improvements across both Healthcare and Diagnostic Services. Net profit rose 32.1%, and cash flow from operations was strong, supporting continued investment and a stable leverage ratio.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.